Tegoprazan to prevent stomach problems after stroke
Treatments studied
Part of Brain & nervous system, Digestive system, Heart & circulation clinical trials.
This study tests a stomach-protecting medicine called tegoprazan for people who have had a stroke and are starting antiplatelet therapy. It aims to prevent stomach complications like ulcers or bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 or older.
- You were just hospitalized for an ischemic stroke or mini-stroke (TIA) and are starting an antiplatelet medicine (like aspirin or clopidogrel) for the first time.
- You have not had a stomach ulcer or gastrointestinal bleeding in the last year.
- You are not currently taking blood thinners (like warfarin or apixaban).
- You can have an endoscopy (a camera test for your stomach) if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, zastaprazan, to see if it can prevent stomach or intestinal bleeding in people who have had a stroke or mini-stroke and are taking blood thinners or anti-clotting drugs. It might help protect your stomach while you're on these medications.
This trial tests a new anti-platelet drug called Tiprogrel to prevent another stroke in people who recently had a minor stroke or a transient ischemic attack (TIA) with certain artery narrowing or plaques. It aims to see if this medicine is safe and works better than current treatments.
This trial tests whether taking aspirin along with either ticagrelor or cilostazol helps prevent another stroke in people who have had a mild stroke or transient ischemic attack (mini-stroke). You must start treatment within 24 hours of your first symptoms.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.